2003•Australian Critical CareRequires access

The use of activated protein C (drotrecogin alfa (activated)) in the treatment of severe sepsis

Margherita Murgo, Harriet Adamson, Martin Boyle

Open publisher page 3 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Drotrecogin alfa, Medicine, Sepsis, Organ dysfunction, Intensive care medicine, Multiple organ dysfunction syndrome, Intensive care, Disseminated intravascular coagulation

Back to paper search Browse research topics Original source

The use of activated protein C (drotrecogin alfa (activated)) in the treatment of severe sepsis — Research Paper | ScholarLens